Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3824505 | Progrès en Urologie | 2013 | 8 Pages |
Abstract
According to our study, there was no superiority of the radical prostatectomy ± adjuvant treatment or the external radiotherapy combining high dose and concomitant short hormonotherapy on the survival without biological recurrence at 5 and 8 years. Many studies confirm that a concomitant hormonotherapy increases the carcinologic control, even with a high rate external beam radiotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
R. Boissier, G. Karsenty, X. Muracciole, L. Daniel, V. Delaporte, C. Maurin, C. Coulange, E. Lechevallier,